Tumor necrosis of lung cancer: detection by Tl-201 and 99mTc-MIBI scinitgraphy

D. P. Sobic-Saranovic, S. Pavlovic, G. Radosavljevic-Asic, N. Kozarevic, D. Jovanovic, V. Obradovic, V. Bosnjakovic (Belgrade, Yugoslavia)

Source: Annual Congress 2002 - Oncology imaging: CT, MRI and PET
Session: Oncology imaging: CT, MRI and PET
Session type: Oral Presentation
Number: 3763
Disease area: Thoracic oncology

Congress or journal article abstract

Abstract

Thallium choride-201 (Tl-201) and technetium-99m hexakis 2-methoxy isobutylisonitrile (99mTc-MIBI) are indicators of tumor viability and they do not accumulate in necrotic tissues. The aim of this study was to evaluate frequency of tumor necrosis in patients with lung cancer by Tl-201 and 99mTc-MIBI scinitgraphy. We studied 44 patients with histollogicaly proven lung cancer divided in two groups: 20 patients in group I (4 pts with small cell lung cancer-SCLC, and 16 pts with non-small cell lung cancer -NSCLC) were injected with 74 MBq of Tl-201, while in Group II 24 patients (5 pts with SCLC and 19 pts with NSCLC) were injected with 370 MBq of 99mTc-MIBI. Thoracic scintigraphy in anterior and posterior projection were acquired in both groups. In case of positive findings, tumor to nontumor (T/NT) ratio was calculated.Results: In Group I 18/20 (90%) patients were found true positive on Tl-201 scinitgraphy, and in 4 of 18 patients (22%) focal uptake with central necrosis was present. In Group II 20/24 (83%) of patients were found true positive on 99mTc-MIBI chest scinitgraphy, while tumor necrosis was found in 5/20 (25%) true positive scinitgrams. No significance differences in mean T/NT ratio between Group I (Tl-201) and Group II (99mTc-MIBI) were detected (1.63 ±] 0.32 vs. 1.61 ±] 0.30,p>0.05, respectively).Conclusion: Our results indicate that primary lung cancer was detected by thoracic scinitgraphy with T-201 and 99mTc-MIBI in 38/44 (86%) patients, and tumor necrosis in 20% (9/44) of them. Both scinitgraphies are noninvasive and effective for the detection of tumor necrosis that may influence the response to treatment of patients with lung cancer.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. P. Sobic-Saranovic, S. Pavlovic, G. Radosavljevic-Asic, N. Kozarevic, D. Jovanovic, V. Obradovic, V. Bosnjakovic (Belgrade, Yugoslavia). Tumor necrosis of lung cancer: detection by Tl-201 and 99mTc-MIBI scinitgraphy. Eur Respir J 2002; 20: Suppl. 38, 3763

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Significance of Tl-201 and MIBI-99mTc lung scintigraphy in advanced lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 247s
Year: 2003

Role of Tc-99m MIBI chest SPECT to detect mediastinal lymph node metastasis in patients with non-small cell lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 314s
Year: 2005

Value of Tc-99m-MIBI scintigraphy in predicting the cytostatic responsiveness of the non-small lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 377s
Year: 2001

Comparison of CT and PET in detection of lung metastases
Source: Annual Congress 2004 - Lung cancer: epidemiology, diagnosis, staging
Year: 2004


99mTc-tetrofosmin (TF) SPECT usefulness in solitary pulmonary nodules
Source: Eur Respir J 2005; 26: Suppl. 49, 212s
Year: 2005

Bone and Tl-201 image overlay in detection of musculoskeletal metastases of lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 245s
Year: 2003

Synchronous primary malignancies identified during staging 18F-FDG PET scan in lung cancer patients
Source: Annual Congress 2010 - Staging of lung cancer
Year: 2010


Scintigraphy with 99mTc-depreotide has a high sensitivity in detecting lung cancer
Source: Annual Congress 2007 - Diagnosis and staging of lung cancer: existing and new techniques
Year: 2007



Radionuclid 99mTc – depreotide in the diagnosis of solitary pulmonary nodules
Source: Eur Respir J 2003; 22: Suppl. 45, 251s
Year: 2003

Radionuclid 99mTc – depreotide in the diagnosis of solitary pulmonary nodules
Source: Eur Respir J 2004; 24: Suppl. 48, 48s
Year: 2004

Comparision of FDG PET/CT and bone scanning for bone metastases in operable non-small cell lung cancer
Source: Annual Congress 2009 - Management of thoracic malignancies
Year: 2009

The use of SPECT in preoperative assessment of patients with lung cancer
Source: Eur Respir J 2004; 24: 258-262
Year: 2004



PET/CT of lung cancer
Source: International Congress 2018 – PG4 Imaging of the chest
Year: 2018


Mediastinoscopy versus CT and PET in preoperative N-staging of lung cancer
Source: Annual Congress 2009 - Current challenges in thoracic surgery
Year: 2009



Increased FDG uptake on 18F-FDG PET/CT in residual lesions of tuberculosis
Source: International Congress 2019 – Tuberculosis: from diagnosis to complications
Year: 2019

The role of 99mTc labelled depreotide scanning in investigating suspected lung cancer - more than just the solitary pulmonary nodule
Source: Eur Respir J 2002; 20: Suppl. 38, 458s
Year: 2002

The estimation of the relative liver perfusion in metastases of bronchus and lung carcinoma by hepatic radionuclide angiography
Source: Eur Respir J 2002; 20: Suppl. 38, 265s
Year: 2002

The use of perfusion SPECT imaging for preoperative evaluation of patients with lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 38s
Year: 2002

A lung cancer patient with multiple lesions on PET scan
Source: Annual Congress 2006 - Clinical Grand Round: an interactive session
Year: 2006

Tc-99m depreotide scintigraphy in the evaluation of solitary pulmonary nodule
Source: Eur Respir J 2005; 26: Suppl. 49, 312s
Year: 2005